Preconditioning Promotes Survival and Angiomyogenic Potential of Mesenchymal Stem Cells in the Infarcted Heart via NF-κB Signaling

Abstract
We proposed that pharmacological manipulation of mesenchymal stem cells (MSCs) with diazoxide enhanced their survival and regenerative potential via NFκB regulation. MSCs preconditioned (PCMSCs) with diazoxide and later subjected to oxidant stress with 100 μmol/L H2O2 either immediately or after 24 h exhibited higher survival (p < 0.01 vs nonpreconditioned MSCs; Non-PCMSCs) with concomitantly increased phosphorylation of PI3K, Akt, GSK3β (cytoplasmic), and NF-κB (p65) (nuclear). Akt kinase activity was determined as a function of GSK3β activity. Pretreatment of PCMSCs with Wortmannin (Wt), NEMO-binding domain (NBD), or NF-κB (p50) siRNA abolished NF-κB (p65) activity. Preconditioning increased NF-κB-dependent elevation of secretable growth factors associated with their paracrine effects. Inhibition of PI3K activity with Wt reduced PCMSCs viability at both early and 24 h time-points. However, inhibition of NF-κB reduced viability of PCMSCs only at 24 h time-point. For in vivo studies, DMEM without cells (group-1) or containing 1 × 106 male Non-PCMSCs (group-2), PCMSCs (group-3), PCMSCs pretreated with Wortmannin (group-4) or NF-κB decoy (group-5) were transplanted in a female rat model of acute myocardial infarction. Group-3 showed highest cell survival and growth factor expression, increased angiomyogenesis, and functional improvement. We conclude that activation of NF-κB by preconditioning promoted PCMSCs survival and angiomyogenic potential in the infarcted heart. Antioxid. Redox Signal. 12, 693–702.